How many insider trades does FilingIQ track for MBIO?

FilingIQ tracks 97 Form 4 insider transactions for MBIO (MUSTANG BIO, INC.), covering filings from Feb 2, 2018 onwards. 1 of those were filed in the last 90 days.

Are MBIO insiders net buyers or net sellers?

Across the full Form 4 history for MBIO, 24 transactions (25%) were open-market purchases and 12 (12%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does MBIO insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is MBIO in?

MUSTANG BIO, INC. (MBIO) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $5.80M.

MBIO insider trading

NasdaqCM Healthcare

MUSTANG BIO, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

25% / 12%

Market cap

$5.80M

About MUSTANG BIO, INC.

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-109, a combination MB-101 and MB-108 as a potential treatment for IL13Ra2+ relapsed or refractory glioblastoma and high-grade astrocytoma; MB-101, an IL13Ra2 CAR T cell program completd Phase I for glioblastoma; and MB-108 which is in Phase I for the treatment of herpes simplex virus-1 oncolytic virus C134. It has a license agreement with city of hope national medical center and nationwide children's hospital. Mustang Bio, Inc. was incorporated in 2015 and is headquartered in Waltham, Massachusetts.

Company website: www.mustangbio.com

MBIO insider activity at a glance

FilingIQ has scored 97 insider transactions for MBIO since Feb 2, 2018. The most recent filing in our index is dated Apr 24, 2026.

Across the full history, 24 open-market purchases and 12 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on MBIO insider trades is 65.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live MBIO trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for MBIO?: FilingIQ tracks 97 Form 4 insider transactions for MBIO (MUSTANG BIO, INC.), covering filings from Feb 2, 2018 onwards. 1 of those were filed in the last 90 days.
Are MBIO insiders net buyers or net sellers?: Across the full Form 4 history for MBIO, 24 transactions (25%) were open-market purchases and 12 (12%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MBIO insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is MBIO in?: MUSTANG BIO, INC. (MBIO) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $5.80M.

Methodology & sources

Every MBIO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.